Thursday| 7 March 2024 | DAY THREE

_____________________________________________________________

8:20-8:30 | Opening Remarks & Introduction - ARI Panel Chairs

• Dr. Yohei Doi | University pf Pittsburgh & Fujita Health University
• Dr. Jorge Vidal | University of Mississippi Medical Center

_____________________________________________________________

SESSION ONE: SARS-CoV 2: Current Advances and Tracking Viral Evolution

8:30-9:00 | The infectivity of SARS-CoV-2 in immunocompromised patients and their de-isolation | Masahiro Ishikane, National Center for Global Health and Medicine, Tokyo, Japan

9:00-9:30 | Epstein-Barr Virus Disrupts Sphingolipid Metabolism to Maintain Viral Latency in Gastric Carcinoma | Suk Kyeong Lee, The Catholic University of Korea

9:30-10:00 | Pathological Analysis of COVID-19 Cases and Animal Model Development | Tadaki Suzuki, National Institute of Infectious Diseases, Tokyo, Japan

10:00-10:30 | The impact of COVID-19 on community and household cohorts in New Zealand | Sue Huang, Ph.D, Institute for Environmental and Science Research, New Zealand

10:30-11:00 | Induction of mucosal antibody responses by SARS-CoV-2 mRNA vaccination in previously infected individuals | Kaori Sano, National Institute of Infectious Diseases, Tokyo, Japan

_____________________________________________________________

11:00-11:10 | Coffee Break

_____________________________________________________________

SESSION TWO: RSV and Other Viral Respiratory Infections

11:10-11:40 | Evaluation of Virus Detection using Quantitative Multiplex PCR in Pediatric Patients Hospitalized with Respiratory Tract Infections | Yuto Yasui, Kawasaki Medical University, Kurashiki, Japan

11:40-12:10 | The impact of influenza A H3N2 evolution from 1968 to 2023 on polymerase activity |
Tohru Sakamoto, Kurume University, Kurume, Japan

12:10-12:40 | Disease burden of respiratory syncytial virus (RSV) infection in the pediatric population in Japan | Koo Nagasawa, Chiba University, Chiba, Japan

_____________________________________________________________

12:40-13:30 | Lunch Break

_____________________________________________________________

SESSION THREE: Influenza: an Emerging and Re-Emerging Pathogen 

13:30-14:00 | Detection of A(H3N2) influenza viruses with PA/I38T drug resistance substitution after and prior to baloxavir marboxil treatment during the 2022-2023 influenza season in Japan | Irina Chon, Niigata University, Niigata, Japan

14:00-14:30 | Does the evolution of human influenza viruses predict influenza epidemics? | Manon Ragonnet-Cronin, Ph.D., University of Chicago, Chicago, IL

14:30-15:00 | CD8+ T cell immunity directed at Influenza A and Influenza B viruses in First Nations peoples | Louise Rowntree, Ph.D., Peter Doherty Institute, Melbourne, Australia

_____________________________________________________________

15:00-15:15 | Break 

_____________________________________________________________

SESSION FOUR: Other Acute Respiratory Infections

15:15-15:45 | Recent trend of respiratory infections in Korea | Hyukmin Lee, MD, PhD, Yonsei University, Seoul, Korea

15:45-16:15 | Pathogens Sticking Together: New Synergies Operative in Polymicrobial Infections |
Jason Rosch, Ph.D., St Jude Children’s Research Hospital, Memphis, USA

16:15-17:15 | Closing Remarks - ARI Panel Chairs

_____________________________________________________________